Assessment of medium-chain triglyceride feeding in infants with cystic fibrosis.
primary studies published RCT
Details- 1969
- Gracey M
A double-blind study of the use of acetylcysteine in patients with cystic fibrosis.
primary studies published RCT
Details- 1966
- Howatt WF
Studies of tocopherol deficiency in infants and children: VI. Evaluation of muscle strength and effect of tocopherol administration in children with cystic fibrosis.
primary studies published RCT
Details- 1961
- Levin S
Non-invasive evaluation of steatosis and fibrosis in the liver in adults patients living with cystic fibrosis.
primary studies published, non RCT
Details- 2025
- Piñar-Gutiérrez A
Evaluating Long-Term Effectiveness of Cystic Fibrosis Modulator Therapies After Rapid Adoption: A Dual-Approach Study.
primary studies published, non RCT
Details- 2025
- Afonso PM
20 years of the Montreal Cystic Fibrosis Related Diabetes Screening Cohort: key insights.
primary studies published, non RCT
Details- 2025
- Alexandre-Heymann L
Respiratory Outcomes and Aspergillus Serology Following Elexacaftor/Tezacaftor/Ivacaftor Therapy in People with Cystic Fibrosis and a History of Aspergillus fumigatus Infection.
primary studies published, non RCT
Details- 2025
- Lanfranchi C
Point of care lung ultrasound in preschool children with cystic fibrosis: a case-controlled, prospective, pilot study.
primary studies published, non RCT
Details- 2024
- Crispino AA
Successful Therapy over 12 Months of People with Cystic Fibrosis with Rare Non-phe508del Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Mutations with Elexacaftor/Tezacaftor/Ivacaftor (ETI).
primary studies published, non RCT
Details- 2024
- Sütering T
Long-term therapy with CFTR modulators consistently improves glucose metabolism in adolescents and adults with cystic fibrosis.
primary studies published, non RCT
Details- 2024
- Cohen A